ワシントンにおける食道腺癌の臨床試験
ワシントン内の拠点で、食道腺癌に関する9件の研究が参加者を募集しています。
ワシントン内の都市
公式研究テキスト(英語)
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- Valley Medical Center, Renton
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Fred Hutchinson Cancer Research Center, Seattle
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06324357Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
- Harborview Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07392892A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Swedish Cancer Institute, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study of KK2269 in Adult Participants With Solid Tumors
- University of Washington, Seattle
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06266299Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Edmonds
- Research Site, Issaquah
- Research Site, Olympia
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Wenatchee Valley Hospital and Clinics, Wenatchee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Northwest Medical Specialities. PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Cancer Institute Edmonds Campus, Edmonds
- 他9件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/05更新 · NCT05563766ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。